New imaging test for dermatomyositis
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial uses a special PET/MRI scan to look at inflammation in the body of people with suspected dermatomyositis. It aims to see if this imaging method can help doctors better understand the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your doctor suspects you have dermatomyositis (a condition causing skin rash and muscle weakness).
- You are not pregnant or possibly pregnant.
- You can safely have an MRI (no metal implants, pacemakers, or trouble lying flat for 30 minutes).
- You are willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging scan (SPECT) that uses a special tracer (99mTc-TCR-FAPI) to see inflammation in the joints of people with rheumatoid arthritis. It aims to help doctors better understand and track disease activity.
This trial uses a special PET/CT scan with a tracer called 68Ga-FAPI-46 to see if it can better detect inflammation and scarring (fibrosis) in people with chronic diseases like scleroderma, pulmonary fibrosis, or rheumatoid arthritis. The goal is to improve diagnosis and monitoring.
This trial tests a new type of PET scan to see if it can accurately spot inflamed or damaged areas in the intestines of people with inflammatory bowel disease (IBD). If it works, it could help doctors track disease activity without relying only on invasive tests.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
Hear when a new Refractory Dermatomyostitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.